Sex
Male
Female
|
141 (58.3)
|
224 (50.7)
|
16 (59.3)
|
22 (56.4)
|
.25
|
|
101 (41.7) |
218 (49.3) |
11 (40.7) |
17 (43.6) |
|
Age†
|
43 (18-90) |
65 (21-96) |
55 (18-75) |
68
(45-80) |
<.001* |
Age group (years)
18–64
65–84
≥85
|
216 (89.3)
|
219 (49.5)
|
20 (74.1)
|
16 (41.0)
|
<.001*
|
|
25 (10.3) |
203 (45.9) |
7 (25.9) |
23 (59.0) |
|
|
1 (0.4) |
20 (4.5) |
0 (0.0) |
0 (0.0) |
|
Intensive care
Yes
No
|
12 (5.0)
|
91 (20.6)
|
9 (33.3)
|
10 (25.6)
|
<.001*
|
|
230 (95.0) |
351 (79.4) |
18 (66.7) |
29 (74.4) |
|
Intubation
Yes
No
|
3 (1.2)
|
53 (12.0)
|
4 (14.8)
|
7 (17.9)
|
<.001*
|
|
239 (98.8) |
389 (88.0) |
23 (85.2) |
32 (82.1) |
|
Complications
Yes
No
|
27 (11.2)
|
94 (21.3)
|
11 (40.7)
|
9 (23.1)
|
<.001*
|
|
215 (88.8) |
348 (78.7) |
16 (59.3) |
30 (76.9) |
|
Survival
Survived
Died
|
238 (98.3)
|
364 (82.4)
|
21 (77.8)
|
26 (66.7)
|
<.001*
|
|
4 (1.7) |
78 (17.6) |
6 (22.2) |
13 (33.3) |
|
Hospitalisation (days)†
|
6 (2-30) |
8 (2-63) |
13
(2-31) |
9 (2-27) |
<.001* |
White blood cell count†, 103/uL |
5.9 (2.0-24.7) |
6.2 (0.5-24.1) |
5.8 (0.5-27.3) |
5.5 (2.0-29.2) |
.141 |
Haemoglobin†, g/dL
|
13,7
(7.1-17.9)
|
12,6
(3.6-19.0)
|
10,7
(6.0-16.0)
|
10,6
(6.4-16.4)
|
<0.001*
|
Platelet count†, 103/uL |
200
(13-570) |
192 (16-594) |
170 (11-435) |
180 (8-591) |
0.078 |
Lymphocyte count†, 103/uL |
1.4
(0.3-3.9) |
1.1 (0.1-9.1) |
0.9 (0.2-6.9) |
0.8 (0.2-13.4) |
<.001* |
Neutrophil/Lymphocyte ratio†
|
2.9 (0.1-41.0) |
3.8
(0.1-63.6) |
2.9 (0.1-39.0) |
3.3 (0.3-32.0) |
<.001* |
Prothrombin time†, s |
12.0 (10.2-16.9) |
12.3
(10.0-29.1) |
12.4 (10.5-17.5) |
12.4 (10.2-33.7) |
.004* |
Activated partial thromboplastin time†, s |
27.6
(3.1-50.0) |
28.3 (18.1-70.2) |
26.9 (20.1-41.7) |
29.5 (18.8-55.8) |
.206 |
Lactic acid dehydrogenase†, U/L |
255 (23-908) |
293
(90-2172) |
320 (139-1634) |
294.5 (133-3600) |
<.001* |
Ferritin†, ng/mL |
208.5 (6-7256) |
336 (13-10000) |
1105 (60-6322) |
733.5 (29-8397) |
<.001* |
D-dimer†, ng/mL |
325 (50-8490) |
721 (38-10000) |
1581 (84-10000) |
1188.5 (193-10000) |
<.001* |
C- reactive protein†, mg/L |
12 (3-435) |
45 (3-422) |
33 (3-300) |
51 (3-282) |
<.001* |
Number of participants |
242 |
442 |
27 |
39 |
|